Cohort of STEMI Patients 2 (HIBISCUS STEMI)
Myocardial Infarction
About this trial
This is an interventional diagnostic trial for Myocardial Infarction focused on measuring Myocardial infarction, bio-collection, Imaging markers, biomarkers, STEMI, clinical outcomes
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years Diagnosis of STEMI defined by ST segment elevation ≥ 0.2 mV in 2 contiguous leads on a 12-lead ECG. Management in primary ACT Prior oral informed consent followed by signed informed consent as soon as possible. Exclusion Criteria: Diagnosis of STEMI not confirmed on angiography Inability to give the subject informed information Lack of coverage by a social security scheme Obvious contraindication to injected magnetic resonance imaging (claustrophobia, pacemaker, defibrillator, or a metallic body (ferromagnetic), severe renal insufficiency (GFR<30 ml/min), known allergy to the contrast medium ....) Pregnant woman or woman of childbearing age without effective contraception, breastfeeding woman. Deprivation of civil rights (curators, guardianship, safeguard of justice)
Sites / Locations
- Hospices Civils de Lyon - Hôpital Louis PradelRecruiting
- Hospices Civils de Lyon - Hôpital de la Croix RousseRecruiting
Arms of the Study
Arm 1
Other
Cohort group
patient with ST-segment elevation myocardial infarction.